These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2217833)

  • 1. Electrophilic levuglandin E2-protein adducts bind glycine: a model for protein crosslinking.
    Jirousek MR; Murthi KK; Salomon RG
    Prostaglandins; 1990 Aug; 40(2):187-203. PubMed ID: 2217833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levuglandin E2 crosslinks proteins.
    Iyer RS; Ghosh S; Salomon RG
    Prostaglandins; 1989 Apr; 37(4):471-80. PubMed ID: 2762557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levuglandin E2-protein adducts in human plasma and vasculature.
    Salomon RG; Subbanagounder G; O'Neil J; Kaur K; Smith MA; Hoff HF; Perry G; Monnier VM
    Chem Res Toxicol; 1997 May; 10(5):536-45. PubMed ID: 9168251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins.
    DiFranco E; Subbanagounder G; Kim S; Murthi K; Taneda S; Monnier VM; Salomon RG
    Chem Res Toxicol; 1995; 8(1):61-7. PubMed ID: 7703368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidation of low-density lipoproteins produces levuglandin-protein adducts.
    Salomon RG; Subbanagounder G; Singh U; O'Neil J; Hoff HF
    Chem Res Toxicol; 1997 Jul; 10(7):750-9. PubMed ID: 9250408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein.
    Salomon RG; Sha W; Brame C; Kaur K; Subbanagounder G; O'Neil J; Hoff HF; Roberts LJ
    J Biol Chem; 1999 Jul; 274(29):20271-80. PubMed ID: 10400646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of DNA-protein cross-links in mammalian cells by levuglandin E2.
    Murthi KK; Friedman LR; Oleinick NL; Salomon RG
    Biochemistry; 1993 Apr; 32(15):4090-7. PubMed ID: 8471616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins.
    Salomon RG; Jirousek MR; Ghosh S; Sharma RB
    Prostaglandins; 1987 Nov; 34(5):643-56. PubMed ID: 3481092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.
    Boutaud O; Brame CJ; Chaurand P; Li J; Rowlinson SW; Crews BC; Ji C; Marnett LJ; Caprioli RM; Roberts LJ; Oates JA
    Biochemistry; 2001 Jun; 40(23):6948-55. PubMed ID: 11389610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levuglandin E2 inhibits mitosis and microtubule assembly.
    Murthi KK; Salomon RG; Sternlicht H
    Prostaglandins; 1990 Jun; 39(6):611-22. PubMed ID: 2115185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid.
    Hoppe G; Subbanagounder G; O'Neil J; Salomon RG; Hoff HF
    Biochim Biophys Acta; 1997 Jan; 1344(1):1-5. PubMed ID: 9022751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.
    Davies SS; Brantley EJ; Voziyan PA; Amarnath V; Zagol-Ikapitte I; Boutaud O; Hudson BG; Oates JA; Roberts LJ
    Biochemistry; 2006 Dec; 45(51):15756-67. PubMed ID: 17176098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the lysyl adducts formed from prostaglandin H2 via the levuglandin pathway.
    Boutaud O; Brame CJ; Salomon RG; Roberts LJ; Oates JA
    Biochemistry; 1999 Jul; 38(29):9389-96. PubMed ID: 10413514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cleavage and cross-linking of proteins with osmium (VII) reagents.
    Emerman M; Behrman EJ
    J Histochem Cytochem; 1982 Apr; 30(4):395-7. PubMed ID: 7061831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reaction of glycolaldehyde with proteins: latent crosslinking potential of alpha-hydroxyaldehydes.
    Acharya AS; Manning JM
    Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3590-4. PubMed ID: 6574500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of gel electrophoresis for the quantitative study of specific ion binding: interaction of phosphate with ovalbumin.
    Ward LD; Winzor DJ
    Arch Biochem Biophys; 1981 Jul; 209(2):650-4. PubMed ID: 7294814
    [No Abstract]   [Full Text] [Related]  

  • 17. The quaternary structure of bovine alpha-crystallin. Chemical crosslinking with bifunctional imido esters.
    Siezen RJ; Bindels JG; Hoenders HJ
    Eur J Biochem; 1980; 107(1):243-9. PubMed ID: 7398636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of EcoP1 modification methylase with S-adenosyl-L-methionine: a UV-crosslinking study.
    Krishnamurthy V; Rao DN
    Biochem Mol Biol Int; 1994 Mar; 32(4):623-32. PubMed ID: 8038713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the association of peptides of optimal length to class I molecules on the surface of cells.
    Rock KL; Rothstein L; Benacerraf B
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8918-22. PubMed ID: 1409586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-crosslinking properties of carnosine: significance of histidine.
    Hobart LJ; Seibel I; Yeargans GS; Seidler NW
    Life Sci; 2004 Jul; 75(11):1379-89. PubMed ID: 15234195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.